0
Startups & Venture·October 22, 2026·1 min read

Ex-OpenAI science head Kevin Weil launches Warp Sciences with $215M

Share

$215M for Warp Sciences to build an automated US lab for a drug development step long outsourced to China is AI plus reshoring in one move. Pharma operators should assume the cost and geography of key wet-lab steps are in play — and revisit make-vs-buy and China-dependency assumptions now, per The Next Web.